Novacyt S.A. (AIM:NCYT)
London · Delayed Price · Currency is GBP · Price in GBX 41.45
+0.50 (1.22%)
Oct 10, 2025, 2:43 PM GMT+1
Novacyt Market Cap
Novacyt has a market cap or net worth of 29.52 million as of October 10, 2025. Its market cap has decreased by -35.57% in one year.
Market Cap
29.52M
Enterprise Value
16.55M
Revenue
19.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
41.45
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 18.97M to 29.52M, an increase of 55.60%. That is a compound annual growth rate of 3.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 29.52M | -15.95% |
| Dec 31, 2024 | 35.12M | -19.57% |
| Dec 29, 2023 | 43.67M | -43.27% |
| Dec 30, 2022 | 76.97M | -70.37% |
| Dec 31, 2021 | 259.78M | -58.11% |
| Dec 31, 2020 | 620.07M | 7,360.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.58B |
| GSK plc | 65.20B |
| Haleon | 30.37B |
| Smith & Nephew | 11.52B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.04B |
| Genus | 1.68B |